5-cyclopropyl-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,3,4-thiadiazol-2-amine;1-N-[3-(2,4-dimethyl-1,3-thiazol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-N,3-N-dimethylbenzene-1,3-diamine;3-N,3-N-dimethyl-1-N-[3-(1,3,5-trimethylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]benzene-1,3-diamine;N-(2-methoxyphenyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,3-benzothiazol-2-amine;3-(1-methylpyrazol-4-yl)-N-[4-(1,2,4-triazol-1-yl)phenyl]imidazo[1,2-a]pyrazin-8-amine
C106H101N43OS3 — CID 157055173
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-cyclopropyl-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,3,4-thiadiazol-2-amine;1-N-[3-(2,4-dimethyl-1,3-thiazol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-N,3-N-dimethylbenzene-1,3-diamine;3-N,3-N-dimethyl-1-N-[3-(1,3,5-trimethylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]benzene-1,3-diamine;N-(2-methoxyphenyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,3-benzothiazol-2-amine;3-(1-methylpyrazol-4-yl)-N-[4-(1,2,4-triazol-1-yl)phenyl]imidazo[1,2-a]pyrazin-8-amine
5-cyclopropyl-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,3,4-thiadiazol-2-amine;1-N-[3-(2,4-dimethyl-1,3-thiazol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-N,3-N-dimethylbenzene-1,3-diamine;3-N,3-N-dimethyl-1-N-[3-(1,3,5-trimethylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]benzene-1,3-diamine;N-(2-methoxyphenyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,3-benzothiazol-2-amine;3-(1-methylpyrazol-4-yl)-N-[4-(1,2,4-triazol-1-yl)phenyl]imidazo[1,2-a]pyrazin-8-amine (PubChem CID 157055173) has the molecular formula C106H101N43OS3 and a molecular weight of 2089.47 g/mol. Its IUPAC name is 5-cyclopropyl-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,3,4-thiadiazol-2-amine;1-N-[3-(2,4-dimethyl-1,3-thiazol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-N,3-N-dimethylbenzene-1,3-diamine;3-N,3-N-dimethyl-1-N-[3-(1,3,5-trimethylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]benzene-1,3-diamine;N-(2-methoxyphenyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,3-benzothiazol-2-amine;3-(1-methylpyrazol-4-yl)-N-[4-(1,2,4-triazol-1-yl)phenyl]imidazo[1,2-a]pyrazin-8-amine.
Molecular Properties
| Compound Name | 5-cyclopropyl-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,3,4-thiadiazol-2-amine;1-N-[3-(2,4-dimethyl-1,3-thiazol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-N,3-N-dimethylbenzene-1,3-diamine;3-N,3-N-dimethyl-1-N-[3-(1,3,5-trimethylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]benzene-1,3-diamine;N-(2-methoxyphenyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,3-benzothiazol-2-amine;3-(1-methylpyrazol-4-yl)-N-[4-(1,2,4-triazol-1-yl)phenyl]imidazo[1,2-a]pyrazin-8-amine |
|---|---|
| PubChem CID | 157055173 |
| Molecular Formula | C106H101N43OS3 |
| Molecular Weight | 2089.47 g/mol |
| Exact Mass | 2087.83 |
| IUPAC Name | 5-cyclopropyl-N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,3,4-thiadiazol-2-amine;1-N-[3-(2,4-dimethyl-1,3-thiazol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-N,3-N-dimethylbenzene-1,3-diamine;3-N,3-N-dimethyl-1-N-[3-(1,3,5-trimethylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]benzene-1,3-diamine;N-(2-methoxyphenyl)-3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-amine;N-[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,3-benzothiazol-2-amine;3-(1-methylpyrazol-4-yl)-N-[4-(1,2,4-triazol-1-yl)phenyl]imidazo[1,2-a]pyrazin-8-amine |
| SMILES | COc1ccccc1Nc1nccn2c(-c3cnn(C)c3)cnc12.Cc1nc(C)c(-c2cnc3c(Nc4cccc(N(C)C)c4)nccn23)s1.Cc1nn(C)c(C)c1-c1cnc2c(Nc3cccc(N(C)C)c3)nccn12.Cn1cc(-c2cnc3c(Nc4ccc(-n5cncn5)cc4)nccn23)cn1.Cn1cc(-c2cnc3c(Nc4nc5ccccc5s4)nccn23)cn1.Cn1cc(-c2cnc3c(Nc4nnc(C5CC5)s4)nccn23)cn1 |
| InChI | InChI=1S/C20H23N7.C19H20N6S.C18H15N9.C17H13N7S.C17H16N6O.C15H14N8S/c1-13-18(14(2)26(5)24-13)17-12-22-20-19(21-9-10-27(17)20)23-15-7-6-8-16(11-15)25(3)4;1-12-17(26-13(2)22-12)16-11-21-19-18(20-8-9-25(16)19)23-14-6-5-7-15(10-14)24(3)4;1-25-10-13(8-22-25)16-9-21-18-17(20-6-7-26(16)18)24-14-2-4-15(5-3-14)27-12-19-11-23-27;1-23-10-11(8-20-23)13-9-19-16-15(18-6-7-24(13)16)22-17-21-12-4-2-3-5-14(12)25-17;1-22-11-12(9-20-22)14-10-19-17-16(18-7-8-23(14)17)21-13-5-3-4-6-15(13)24-2;1-22-8-10(6-18-22)11-7-17-13-12(16-4-5-23(11)13)19-15-21-20-14(24-15)9-2-3-9/h6-12H,1-5H3,(H,21,23);5-11H,1-4H3,(H,20,23);2-12H,1H3,(H,20,24);2-10H,1H3,(H,18,21,22);3-11H,1-2H3,(H,18,21);4-9H,2-3H2,1H3,(H,16,19,21) |
| InChIKey | AAQZZFAFZUMSRN-UHFFFAOYSA-N |
| XLogP | 19.26 |
| TPSA | 440.40 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 47 |
| Rotatable Bonds | 23 |
| Heavy Atoms | 153 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2089.47 |
| LogP ≤ 5 | 19.26 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 47 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157055173 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.